Peripheral Arterial Disease (PAD) is a major Public Health Crisis:

• PAD Patients > 200 million worldwide
• Majority are over age 65 (double by 2040)
• ~900,000 PAD procedures per year
• ~ 57% are reinterventions

Current Practice for all PAD procedures (diagnostic and interventional) is unidirectional ONLY (Medtronic, Cordis, Terumo, Cook, Merit).

DeTour Sheath allows bi-directional diagnosis and intervention in the same procedure:

• Overall cost savings for hospitals and outpatient centers (~$250 million per year)
• ↓ Total number of interventions & use of closure devices
• ↓ Access site complications by 50%
• Projected Sheath Cost per unit à (~ $150)